자베게판트: 급성기 편두통 치료의 코투여 약물

Zavegepant: Intranasal Drug for Acute Migraine Treatmen

초록

Calcitonin gene-related peptide (CGRP) is probably the most potent vasodilator in cerebral circulation. The new CGRP-targeted therapy for the treatment of acute treatment are now available for clinical practice. This review article summarized efficacy and safety of zavegepant, which is the first intranasal small molecule CGRP receptor antagonist for acute migraine treatment.

키워드

Calcitonin gene-related peptide; Migraine; Zavegepant
제목
자베게판트: 급성기 편두통 치료의 코투여 약물
제목 (타언어)
Zavegepant: Intranasal Drug for Acute Migraine Treatmen
저자
서종근
발행일
2023-06
유형
Y
저널명
두통
권
24
호
1
페이지
17 ~ 19